SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SULFATION PATHWAYS: Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects
Authors
Keywords
-
Journal
JOURNAL OF MOLECULAR ENDOCRINOLOGY
Volume 61, Issue 2, Pages T233-T252
Publisher
Bioscientifica
Online
2018-04-04
DOI
10.1530/jme-18-0045
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Acquired resistance to aromatase inhibitors: where we stand!
- (2018) Tiago Vieira Augusto et al. ENDOCRINE-RELATED CANCER
- Quinazolinone-Based Anticancer Agents: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Tubulin Co-crystal Structure
- (2018) Wolfgang Dohle et al. JOURNAL OF MEDICINAL CHEMISTRY
- Microenvironmental control of breast cancer subtype elicited through paracrine platelet-derived growth factor-CC signaling
- (2018) Pernilla Roswall et al. NATURE MEDICINE
- Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
- (2018) Hitisha K. Patel et al. PHARMACOLOGY & THERAPEUTICS
- Hormonal therapy for endometriosis: from molecular research to bedside
- (2017) Claudia Tosti et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer
- (2017) Patricia Pautier et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER
- (2017) Lorna C Gilligan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- First Dual Inhibitors of Steroid Sulfatase (STS) and 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): Designed Multiple Ligands as Novel Potential Therapeutics for Estrogen-Dependent Diseases
- (2017) Mohamed Salah et al. JOURNAL OF MEDICINAL CHEMISTRY
- Estradiol prodrugs (EP) for efficient oral estrogen treatment and abolished effects on estrogen modulated liver functions
- (2017) W. Elger et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
- (2017) Nicholas D. James et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical significance of the estrogen-modifying enzymes steroid sulfatase and estrogen sulfotransferase in epithelial ovarian cancer
- (2017) Felicitas Mungenast et al. Oncology Letters
- Human steroid sulfatase induces Wnt/β-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1α in human prostate and cervical cancer cells
- (2017) Sangyun Shin et al. Oncotarget
- The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers
- (2017) Tea Lanišnik Rižner et al. Frontiers in Pharmacology
- Clinical Implications of ESR1 Mutations in Hormone Receptor-Positive Advanced Breast Cancer
- (2017) Tomas Reinert et al. Frontiers in Oncology
- 1638PSTEROID SULFATASE PROMOTES INVASION AND IS A USEFUL MARKER FOR PREDICTING THE PROGRESSION OF BLADDER CANCER
- (2017) S. Eri et al. ANNALS OF ONCOLOGY
- Microtubule destabilising agents: far more than just antimitotic anticancer drugs
- (2016) Darcy Bates et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
- (2016) Hope S. Rugo et al. JOURNAL OF CLINICAL ONCOLOGY
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years
- (2016) Paul E. Goss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Palbociclib and Letrozole in Advanced Breast Cancer
- (2016) Richard S. Finn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Steroid Sulfatase as a Prognostic Factor in Patients with Endometrial Cancer
- (2016) Won Moo Lee et al. YONSEI MEDICAL JOURNAL
- Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer
- (2016) Toru Higuchi et al. PLoS One
- Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol
- (2015) Yu-chi Shen et al. BRITISH JOURNAL OF CANCER
- Sensitive Detection of Mono- and Polyclonal ESR1 Mutations in Primary Tumors, Metastatic Lesions, and Cell-Free DNA of Breast Cancer Patients
- (2015) P. Wang et al. CLINICAL CANCER RESEARCH
- The Regulation of Steroid Action by Sulfation and Desulfation
- (2015) Jonathan W. Mueller et al. ENDOCRINE REVIEWS
- Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women’s Health
- (2015) Mark P. Thomas et al. JOURNAL OF MEDICINAL CHEMISTRY
- Estrogen O-sulfamates and their analogues: Clinical steroid sulfatase inhibitors with broad potential
- (2015) Mark P. Thomas et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- The intracrinology of breast cancer
- (2015) Keely May McNamara et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- All sex steroids are made intracellularly in peripheral tissues by the mechanisms of intracrinology after menopause
- (2015) Fernand Labrie JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Evidence of estrone-sulfate uptake modification in young and middle-aged rat prostate
- (2015) Frank Giton et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- (2015) LANCET
- Role of 2-methoxyestradiol, an Endogenous Estrogen Metabolite, in Health and Disease
- (2015) Alexis Parada-Bustamante et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer
- (2014) C Stengel et al. BRITISH JOURNAL OF CANCER
- Experimental and Theoretical Insights into the Mechanisms of Sulfate and Sulfamate Ester Hydrolysis and the End Products of Type I Sulfatase Inactivation by Aryl Sulfamates
- (2014) Spencer J. Williams et al. JOURNAL OF ORGANIC CHEMISTRY
- Synergistic Effects of E2MATE and Norethindrone Acetate on Steroid Sulfatase Inhibition
- (2014) Oliver Pohl et al. Reproductive Sciences
- A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
- (2013) R. Charles Coombes et al. BREAST CANCER RESEARCH AND TREATMENT
- The structural biology of oestrogen metabolism
- (2013) Mark P. Thomas et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
- (2013) Jack Cuzick et al. LANCET
- Inhibition of dehydroepiandosterone sulfate action in androgen-sensitive tissues by EM-1913, an inhibitor of steroid sulfatase
- (2013) Jenny Roy et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Endometriosis: pathogenesis and treatment
- (2013) Paolo Vercellini et al. Nature Reviews Endocrinology
- STX140, but Not Paclitaxel, Inhibits Mammary Tumour Initiation and Progression in C3(1)/SV40 T/t-Antigen Transgenic Mice
- (2013) Florence Meyer-Losic et al. PLoS One
- Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
- (2012) Jean-Francois Peyrat et al. CURRENT MEDICINAL CHEMISTRY
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial
- (2012) Christina Davies et al. LANCET
- 2-Methoxyestradiol inhibits experimental autoimmune encephalomyelitis through suppression of immune cell activation
- (2012) G. S. Duncan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synthesis of 2-[11C]methoxy-3,17β-O,O-bis(sulfamoyl)estradiol as a new potential PET agent for imaging of steroid sulfatase (STS) in cancers
- (2012) Min Wang et al. STEROIDS
- Structure-Activity Relationship for the First-in-Class Clinical Steroid Sulfatase Inhibitor Irosustat (STX64, BN83495)
- (2011) L. W. Lawrence Woo et al. ChemMedChem
- 7047 POSTER A Phase I Pharmacodynamic Dose Escalation Study of Steroid Sulphatase Inhibitor Irosustat in Patients With Prostate Cancer
- (2011) S. Denmeade et al. EUROPEAN JOURNAL OF CANCER
- Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer
- (2011) José Baselga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased estrogen sulfatase (STS) and 17β-hydroxysteroid dehydrogenase type 1(17β-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients
- (2010) Niramol Chanplakorn et al. BREAST CANCER RESEARCH AND TREATMENT
- Chimeric microtubule disruptors
- (2010) Mathew P. Leese et al. CHEMICAL COMMUNICATIONS
- Highly Potent First Examples of Dual Aromatase−Steroid Sulfatase Inhibitors based on a Biphenyl Template†
- (2010) L. W. Lawrence Woo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity
- (2010) L. W. Lawrence Woo et al. ACS Medicinal Chemistry Letters
- The Development of Steroid Sulfatase Inhibitors for Hormone-Dependent Cancer Therapy
- (2009) Joanna M. Day et al. Annals of the New York Academy of Sciences
- Phase I Trial of 2-Methoxyestradiol NanoCrystal Dispersion in Advanced Solid Malignancies
- (2009) A. J. Tevaarwerk et al. CLINICAL CANCER RESEARCH
- Design and synthesis of carbon-11-labeled dual aromatase–steroid sulfatase inhibitors as new potential PET agents for imaging of aromatase and steroid sulfatase expression in breast cancer
- (2009) Min Wang et al. STEROIDS
- Direct Evidence for ArOS Bond Cleavage upon Inactivation ofPseudomonas aeruginosa Arylsulfatase by Aryl Sulfamates
- (2008) Pavla Bojarová et al. CHEMBIOCHEM
- STX140 Is Efficacious In vitro and In vivo in Taxane-Resistant Breast Carcinoma Cells
- (2008) S. P. Newman et al. CLINICAL CANCER RESEARCH
- A New Therapeutic Strategy against Hormone-Dependent Breast Cancer: The Preclinical Development of a Dual Aromatase and Sulfatase Inhibitor
- (2008) P. A. Foster et al. CLINICAL CANCER RESEARCH
- The Use of Steroid Sulfatase Inhibitors as a Novel Therapeutic Strategy Against Hormone-Dependent Endometrial Cancer
- (2008) Paul A. Foster et al. ENDOCRINOLOGY
- Estrone sulfatase activity in patients with advanced ovarian cancer
- (2008) Justin C. Chura et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now